Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05827081
Title Phase IIIb Study of Ribociclib + ET in Early Breast Cancer (Adjuvant WIDER)
Acronym Adjuvant WIDER
Recruitment Suspended
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: adult | senior
Covered Countries AUS

No variant requirements are available.